Molecular changes track recurrence and progression of bronchial precancerous lesions

Lung Cancer

Volumn 37, Issue 3, 2002, Pages 267-270

  Sozzi, Gabriella ^a   Oggionni, Maria ^b   Alasio, Loredana ^b   Conte, Davide ^a   Tavecchio, Luca ^b   Pilotti, Silvana ^b   Spinelli, Pasquale ^b   Calarco, Giuseppe ^b  

^a Unit of Molecular Therapies   (Italy)

^b NATIONAL CANCER INSTITUTE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

FRAGILE HISTIDINE TRIAD PROTEIN; PROTEIN P53;

AGED; ALLELE; ARTICLE; BRONCHOSCOPY; BRONCHUS INJURY; CANCER GROWTH; CANCER RECURRENCE; CANCER RISK; CLINICAL ARTICLE; CONTROLLED STUDY; FLUORESCENCE; FOLLOW UP; GENE MUTATION; HETEROZYGOSITY LOSS; HIGH RISK PATIENT; HUMAN; IMMUNOREACTIVITY; LASER; LUNG SMALL CELL CANCER; PREDICTION; PRIORITY JOURNAL; RISK ASSESSMENT;

ACID ANHYDRIDE HYDROLASES; AGED; BRONCHOSCOPY; DISEASE PROGRESSION; GENETIC MARKERS; HUMANS; LONGITUDINAL STUDIES; LUNG NEOPLASMS; MALE; NEOPLASM PROTEINS; NEOPLASM RECURRENCE, LOCAL; PRECANCEROUS CONDITIONS; RISK ASSESSMENT; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0036754197     PISSN: 01695002     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0169-5002(02)00079-X     Document Type: Article

References (16)

1. Lam S., MacAulay C., Hung J., et al. Detection of dysplasia and carcinoma in situ with a lung imaging fluorescence endoscope device. J. Thorac. Cardiovasc. Surg. 5:1993;1035-1040.
2. Kurie J.M., Lee J.S., Morice R.C., et al. Autofluorescence bronchoscopy in the detection of squamous metaplasia and dysplasia in current and former smokers. J. Natl. Cancer Inst. 90:1998;991-995.
3. Sozzi G., Miozzo M., Donghi R., et al. Deletions of 17p and p53 mutations in preneoplastic lesions of the lung. Cancer Res. 52:1992;6079-6082.
4. Sozzi G., Miozzo M., Pastorino U., et al. Genetic evidence of field cancerization in patients with multiple synchronous tumors of the lung. Cancer Res. 55:1995;135-140.
5. Gazdar A.F. Molecular changes preceding the onset of invasive lung cancers. Lung Cancer. 00:1994;16-17.
6. Hung J., Kishimoto Y., Sugio K., et al. Allele-specific chromosome 3p deletions occur at an early stage in the pathogenesis of lung carcinoma. J. Am. Med. Assoc. 273:1995;558-563. (published erratum appears in J. Am. Med. Assoc. 1995;273(24):1908).
7. Sundaresan V., Ganly P., Haselton P., et al. p53 and chromosome 3 abnormalities, characteristic of malignant lung tumours, are detectable in preinvasive lesions of the bronchus. Oncogene. 7:1992;1989-1997.
8. Mao L., Lee J.S., Kurie J.M., et al. Clonal genetic alterations in the lungs of current and former smokers. J. Natl. Cancer Inst. 89:1997;857-862.
9. Wistuba I.I., Lam S., Behrens C., et al. Molecular damage in the bronchial epithelium of current and former smokers. J. Natl. Cancer Inst. 89:1997;1366-1373.
10. Thiberville L., Payne P., Vielkinds J., et al. Evidence of cumulative gene losses with progression of premalignant epithelial lesions to carcinoma of the bronchus. Cancer Res. 55:1995;5133-5139.
11. Sozzi G., Pastorino U., Moiraghi L., et al. Loss of FHIT function in lung cancer and preinvasive bronchial lesions. Cancer Res. 58:1998;5032-5037.
12. Sozzi G., Tornielli S., Tagliabue E., et al. Absence of Fhit protein in primary lung tumors and cell lines with FHIT gene abnormalities. Cancer Res. 57:1997;5207-5212.
13. Dal Fante M., De Paoli E., Pilotti S., Pinelli P. Fluorescence bronchoscopy in early detection of lung cancer. Eur. J. Cancer A. 32:1996;58.
14. Spinelli P. Photofrin: marking a decade of experience, results of an international enquiry on clinical application of PDT. Eur. J. Cancer Care. 8:1999;4-9.
15. Denissenko M.F., Pao A., Tang M., et al. Preferential formation of benzo[alpha]pyrene adducts at lung cancer mutational hotspots in P53. Science. 74:1996;430.
16. Ibrahim S.O., Vasstrand E.N., Johannessen A.C., et al. Mutations of p53 gene in oral squamous-cell carcinomas from Sudanese dippers of nitrosamine-rich toombak and non-snuff-dippers from Sudan and Scandinavia. Int. J. Cancer. 81:1999;527-534.